AIMS: Pulmonary vein ganglia (PVG) are targets for atrial fibrillation ablation. However, the functional relevance of PVG to the normal heart rhythm remains unclear. Our aim was to investigate whether PVG can modulate sinoatrial node (SAN) function. METHODS AND RESULTS: Forty-nine C57BL and seven Connexin40+/EGFP mice were studied. We used tyrosine-hydroxylase (TH) and choline-acetyltransferase immunofluorescence labelling to characterize adrenergic and cholinergic neural elements. PVG projected postganglionic nerves to the SAN, which entered the SAN as an extensive, mesh-like neural network. PVG neurones were adrenergic, cholinergic, and biphenotypic. Histochemical characterization of two human embryonic hearts showed similarities between mouse and human neuroanatomy: direct neural communications between PVG and SAN. In Langendorff perfused mouse hearts, PVG were stimulated using 200-2000 ms trains of pulses (300 μs, 400 µA, 200 Hz). PVG stimulation caused an initial heart rate (HR) slowing (36 ± 9%) followed by acceleration. PVG stimulation in the presence of propranolol caused HR slowing (43 ± 13%) that was sustained over 20 beats. PVG stimulation with atropine progressively increased HR. Time-course effects were enhanced with 1000 and 2000 ms trains (P < 0.05 vs. 200 ms). In optical mapping, PVG stimulation shifted the origin of SAN discharges. In five paroxysmal AF patients undergoing pulmonary vein ablation, application of radiofrequency energy to the PVG area during sinus rhythm produced a decrease in HR similar to that observed in isolated mouse hearts. CONCLUSION: PVG have functional and anatomical biphenotypic characteristics. They can have significant effects on the electrophysiological control of the SAN.
AIMS: Pulmonary vein ganglia (PVG) are targets for atrial fibrillation ablation. However, the functional relevance of PVG to the normal heart rhythm remains unclear. Our aim was to investigate whether PVG can modulate sinoatrial node (SAN) function. METHODS AND RESULTS: Forty-nine C57BL and seven Connexin40+/EGFP mice were studied. We used tyrosine-hydroxylase (TH) and choline-acetyltransferase immunofluorescence labelling to characterize adrenergic and cholinergic neural elements. PVG projected postganglionic nerves to the SAN, which entered the SAN as an extensive, mesh-like neural network. PVG neurones were adrenergic, cholinergic, and biphenotypic. Histochemical characterization of two human embryonic hearts showed similarities between mouse and human neuroanatomy: direct neural communications between PVG and SAN. In Langendorff perfused mouse hearts, PVG were stimulated using 200-2000 ms trains of pulses (300 μs, 400 µA, 200 Hz). PVG stimulation caused an initial heart rate (HR) slowing (36 ± 9%) followed by acceleration. PVG stimulation in the presence of propranolol caused HR slowing (43 ± 13%) that was sustained over 20 beats. PVG stimulation with atropine progressively increased HR. Time-course effects were enhanced with 1000 and 2000 ms trains (P < 0.05 vs. 200 ms). In optical mapping, PVG stimulation shifted the origin of SAN discharges. In five paroxysmal AFpatients undergoing pulmonary vein ablation, application of radiofrequency energy to the PVG area during sinus rhythm produced a decrease in HR similar to that observed in isolated mouse hearts. CONCLUSION: PVG have functional and anatomical biphenotypic characteristics. They can have significant effects on the electrophysiological control of the SAN.
Authors: Kristina Rysevaite; Inga Saburkina; Neringa Pauziene; Raimundas Vaitkevicius; Sami F Noujaim; José Jalife; Dainius H Pauza Journal: Heart Rhythm Date: 2011-01-11 Impact factor: 6.343
Authors: Axel Bauer; Isabel Deisenhofer; Raphael Schneider; Bernhard Zrenner; Petra Barthel; Martin Karch; Stefan Wagenpfeil; Claus Schmitt; Georg Schmidt Journal: Heart Rhythm Date: 2006-08-30 Impact factor: 6.343
Authors: Shaowei Zhuang; Youhua Zhang; Kent A Mowrey; Jianbo Li; Tomotsugu Tabata; Don W Wallick; Zoran B Popović; Richard A Grimm; Andrea Natale; Todor N Mazgalev Journal: Circulation Date: 2002-10-01 Impact factor: 29.690
Authors: Conrado J Calvo; Wilson M Lozano; Óscar J Arias-Mutis; Luis Such-Miquel; Luis Such; Patricia Genovés; Antonio Guill; José Millet; Francisco J Chorro; Antonio Alberola; Sandeep V Pandit; Manuel Zarzoso Journal: J Physiol Biochem Date: 2019-03-18 Impact factor: 4.158
Authors: Yu Xu; Lucas Cantwell; Andrei I Molosh; Leigh D Plant; Dimitris Gazgalis; Stephanie D Fitz; Erik T Dustrude; Yuchen Yang; Takeharu Kawano; Sumanta Garai; Sami F Noujaim; Anantha Shekhar; Diomedes E Logothetis; Ganesh A Thakur Journal: J Biol Chem Date: 2020-01-17 Impact factor: 5.157
Authors: Peter Hanna; Michael J Dacey; Jaclyn Brennan; Alison Moss; Shaina Robbins; Sirisha Achanta; Natalia P Biscola; Mohammed A Swid; Pradeep S Rajendran; Shumpei Mori; Joseph E Hadaya; Elizabeth H Smith; Stanley G Peirce; Jin Chen; Leif A Havton; Zixi Jack Cheng; Rajanikanth Vadigepalli; James Schwaber; Robert L Lux; Igor Efimov; John D Tompkins; Donald B Hoover; Jeffrey L Ardell; Kalyanam Shivkumar Journal: Circ Res Date: 2021-02-25 Impact factor: 17.367
Authors: Beth A Habecker; Mark E Anderson; Susan J Birren; Keiichi Fukuda; Neil Herring; Donald B Hoover; Hideaki Kanazawa; David J Paterson; Crystal M Ripplinger Journal: J Physiol Date: 2016-06-17 Impact factor: 5.182
Authors: Obada Abouassali; Mengmeng Chang; Bojjibabu Chidipi; Jose Luis Martinez; Michelle Reiser; Manasa Kanithi; Ravi Soni; Thomas V McDonald; Bengt Herweg; Javier Saiz; Laurent Calcul; Sami F Noujaim Journal: Am J Physiol Heart Circ Physiol Date: 2020-11-20 Impact factor: 4.733